Page 30 - Andreaf Wainer News Today

Oppenheimer & Co. Inc. increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 106,641 shares of the healthcare product maker’s stock after acquiring an additional 7,013 shares during the […]

Kestra Private Wealth Services LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.3% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 101,652 shares of the healthcare product maker’s stock after acquiring an additional 9,470 […]

Valmark Advisers Inc. lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 15,521 shares of the healthcare product maker’s stock after buying an additional 236 shares during the quarter. Valmark Advisers Inc.’s holdings in Abbott Laboratories were worth $1,503,000 at […]

Fidelis Capital Partners LLC raised its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.2% in the 3rd quarter, Holdings Channel reports. The firm owned 14,594 shares of the healthcare product maker’s stock after purchasing an additional 317 shares during the quarter. Fidelis Capital Partners LLC’s holdings in Abbott Laboratories were worth […]

Prosperity Financial Group Inc. lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,431 shares of the healthcare product maker’s stock after acquiring an additional 144 shares […]

Merit Financial Group LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,892 shares of the healthcare product maker’s stock after buying an additional 1,470 […]

Motco raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 12.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,072 shares of the healthcare product maker’s stock after buying an additional 119 shares during the quarter. Motco’s holdings in Abbott Laboratories […]

Oppenheimer Asset Management Inc. lowered its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 19.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 199,220 shares of the healthcare product maker’s stock after selling 47,694 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings […]

Marco Investment Management LLC decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 69,138 shares of the healthcare product maker’s stock after selling 2,095 shares during the quarter. Marco Investment Management […]

Great Lakes Advisors LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 28.6% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,316,125 shares of the healthcare product maker’s stock after acquiring an additional 292,882 shares during the quarter. Abbott Laboratories accounts for approximately 1.2% of Great Lakes Advisors […]